[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Natural Killer Cell Therapy Market Growth (Status and Outlook) 2024-2030

January 2024 | 109 pages | ID: G123DA3A1E8DEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Natural Killer Cell Therapy market size was valued at US$ 250.2 million in 2023. With growing demand in downstream market, the Natural Killer Cell Therapy is forecast to a readjusted size of US$ 1200.2 million by 2030 with a CAGR of 25.1% during review period.

The research report highlights the growth potential of the global Natural Killer Cell Therapy market. Natural Killer Cell Therapy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Natural Killer Cell Therapy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Natural Killer Cell Therapy market.

Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.

The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.

Based on application, the market is classified into cancer, gastrointestinal diseases and others. The cancer segment accounted for a major share in 2019 (66.99%).

Major players operating in the market include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics and etc. The Top 6 players accounted for 96.66% of the global revenue market share in 2019.

Key Features:

The report on Natural Killer Cell Therapy market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Natural Killer Cell Therapy market. It may include historical data, market segmentation by Type (e.g., NK Cell Therapies, NK Cell Directed Antibodies), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Natural Killer Cell Therapy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Natural Killer Cell Therapy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Natural Killer Cell Therapy industry. This include advancements in Natural Killer Cell Therapy technology, Natural Killer Cell Therapy new entrants, Natural Killer Cell Therapy new investment, and other innovations that are shaping the future of Natural Killer Cell Therapy.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Natural Killer Cell Therapy market. It includes factors influencing customer ' purchasing decisions, preferences for Natural Killer Cell Therapy product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Natural Killer Cell Therapy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Natural Killer Cell Therapy market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Natural Killer Cell Therapy market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Natural Killer Cell Therapy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Natural Killer Cell Therapy market.

Market Segmentation:

Natural Killer Cell Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
  • NK Cell Therapies
  • NK Cell Directed Antibodies
Segmentation by application
  • Cancer
  • Gastrointestinal Diseases
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Nektar Therapeutics
  • Innate Pharma SA
  • Affimed
  • Chipscreen Biosciences
  • Glycostem Therapeutics
  • Fate Therapeutics
  • Dragonfly Therapeutics
  • Kiadis Pharma
  • Nkarta Therapeutics
  • NantKwest
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Natural Killer Cell Therapy Market Size 2019-2030
  2.1.2 Natural Killer Cell Therapy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Natural Killer Cell Therapy Segment by Type
  2.2.1 NK Cell Therapies
  2.2.2 NK Cell Directed Antibodies
2.3 Natural Killer Cell Therapy Market Size by Type
  2.3.1 Natural Killer Cell Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Natural Killer Cell Therapy Market Size Market Share by Type (2019-2024)
2.4 Natural Killer Cell Therapy Segment by Application
  2.4.1 Cancer
  2.4.2 Gastrointestinal Diseases
  2.4.3 Others
2.5 Natural Killer Cell Therapy Market Size by Application
  2.5.1 Natural Killer Cell Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Natural Killer Cell Therapy Market Size Market Share by Application (2019-2024)

3 NATURAL KILLER CELL THERAPY MARKET SIZE BY PLAYER

3.1 Natural Killer Cell Therapy Market Size Market Share by Players
  3.1.1 Global Natural Killer Cell Therapy Revenue by Players (2019-2024)
  3.1.2 Global Natural Killer Cell Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Natural Killer Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 NATURAL KILLER CELL THERAPY BY REGIONS

4.1 Natural Killer Cell Therapy Market Size by Regions (2019-2024)
4.2 Americas Natural Killer Cell Therapy Market Size Growth (2019-2024)
4.3 APAC Natural Killer Cell Therapy Market Size Growth (2019-2024)
4.4 Europe Natural Killer Cell Therapy Market Size Growth (2019-2024)
4.5 Middle East & Africa Natural Killer Cell Therapy Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Natural Killer Cell Therapy Market Size by Country (2019-2024)
5.2 Americas Natural Killer Cell Therapy Market Size by Type (2019-2024)
5.3 Americas Natural Killer Cell Therapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Natural Killer Cell Therapy Market Size by Region (2019-2024)
6.2 APAC Natural Killer Cell Therapy Market Size by Type (2019-2024)
6.3 APAC Natural Killer Cell Therapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Natural Killer Cell Therapy by Country (2019-2024)
7.2 Europe Natural Killer Cell Therapy Market Size by Type (2019-2024)
7.3 Europe Natural Killer Cell Therapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Natural Killer Cell Therapy by Region (2019-2024)
8.2 Middle East & Africa Natural Killer Cell Therapy Market Size by Type (2019-2024)
8.3 Middle East & Africa Natural Killer Cell Therapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL NATURAL KILLER CELL THERAPY MARKET FORECAST

10.1 Global Natural Killer Cell Therapy Forecast by Regions (2025-2030)
  10.1.1 Global Natural Killer Cell Therapy Forecast by Regions (2025-2030)
  10.1.2 Americas Natural Killer Cell Therapy Forecast
  10.1.3 APAC Natural Killer Cell Therapy Forecast
  10.1.4 Europe Natural Killer Cell Therapy Forecast
  10.1.5 Middle East & Africa Natural Killer Cell Therapy Forecast
10.2 Americas Natural Killer Cell Therapy Forecast by Country (2025-2030)
  10.2.1 United States Natural Killer Cell Therapy Market Forecast
  10.2.2 Canada Natural Killer Cell Therapy Market Forecast
  10.2.3 Mexico Natural Killer Cell Therapy Market Forecast
  10.2.4 Brazil Natural Killer Cell Therapy Market Forecast
10.3 APAC Natural Killer Cell Therapy Forecast by Region (2025-2030)
  10.3.1 China Natural Killer Cell Therapy Market Forecast
  10.3.2 Japan Natural Killer Cell Therapy Market Forecast
  10.3.3 Korea Natural Killer Cell Therapy Market Forecast
  10.3.4 Southeast Asia Natural Killer Cell Therapy Market Forecast
  10.3.5 India Natural Killer Cell Therapy Market Forecast
  10.3.6 Australia Natural Killer Cell Therapy Market Forecast
10.4 Europe Natural Killer Cell Therapy Forecast by Country (2025-2030)
  10.4.1 Germany Natural Killer Cell Therapy Market Forecast
  10.4.2 France Natural Killer Cell Therapy Market Forecast
  10.4.3 UK Natural Killer Cell Therapy Market Forecast
  10.4.4 Italy Natural Killer Cell Therapy Market Forecast
  10.4.5 Russia Natural Killer Cell Therapy Market Forecast
10.5 Middle East & Africa Natural Killer Cell Therapy Forecast by Region (2025-2030)
  10.5.1 Egypt Natural Killer Cell Therapy Market Forecast
  10.5.2 South Africa Natural Killer Cell Therapy Market Forecast
  10.5.3 Israel Natural Killer Cell Therapy Market Forecast
  10.5.4 Turkey Natural Killer Cell Therapy Market Forecast
  10.5.5 GCC Countries Natural Killer Cell Therapy Market Forecast
10.6 Global Natural Killer Cell Therapy Forecast by Type (2025-2030)
10.7 Global Natural Killer Cell Therapy Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Nektar Therapeutics
  11.1.1 Nektar Therapeutics Company Information
  11.1.2 Nektar Therapeutics Natural Killer Cell Therapy Product Offered
  11.1.3 Nektar Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Nektar Therapeutics Main Business Overview
  11.1.5 Nektar Therapeutics Latest Developments
11.2 Innate Pharma SA
  11.2.1 Innate Pharma SA Company Information
  11.2.2 Innate Pharma SA Natural Killer Cell Therapy Product Offered
  11.2.3 Innate Pharma SA Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Innate Pharma SA Main Business Overview
  11.2.5 Innate Pharma SA Latest Developments
11.3 Affimed
  11.3.1 Affimed Company Information
  11.3.2 Affimed Natural Killer Cell Therapy Product Offered
  11.3.3 Affimed Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Affimed Main Business Overview
  11.3.5 Affimed Latest Developments
11.4 Chipscreen Biosciences
  11.4.1 Chipscreen Biosciences Company Information
  11.4.2 Chipscreen Biosciences Natural Killer Cell Therapy Product Offered
  11.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Chipscreen Biosciences Main Business Overview
  11.4.5 Chipscreen Biosciences Latest Developments
11.5 Glycostem Therapeutics
  11.5.1 Glycostem Therapeutics Company Information
  11.5.2 Glycostem Therapeutics Natural Killer Cell Therapy Product Offered
  11.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Glycostem Therapeutics Main Business Overview
  11.5.5 Glycostem Therapeutics Latest Developments
11.6 Fate Therapeutics
  11.6.1 Fate Therapeutics Company Information
  11.6.2 Fate Therapeutics Natural Killer Cell Therapy Product Offered
  11.6.3 Fate Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Fate Therapeutics Main Business Overview
  11.6.5 Fate Therapeutics Latest Developments
11.7 Dragonfly Therapeutics
  11.7.1 Dragonfly Therapeutics Company Information
  11.7.2 Dragonfly Therapeutics Natural Killer Cell Therapy Product Offered
  11.7.3 Dragonfly Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Dragonfly Therapeutics Main Business Overview
  11.7.5 Dragonfly Therapeutics Latest Developments
11.8 Kiadis Pharma
  11.8.1 Kiadis Pharma Company Information
  11.8.2 Kiadis Pharma Natural Killer Cell Therapy Product Offered
  11.8.3 Kiadis Pharma Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Kiadis Pharma Main Business Overview
  11.8.5 Kiadis Pharma Latest Developments
11.9 Nkarta Therapeutics
  11.9.1 Nkarta Therapeutics Company Information
  11.9.2 Nkarta Therapeutics Natural Killer Cell Therapy Product Offered
  11.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Nkarta Therapeutics Main Business Overview
  11.9.5 Nkarta Therapeutics Latest Developments
11.10 NantKwest
  11.10.1 NantKwest Company Information
  11.10.2 NantKwest Natural Killer Cell Therapy Product Offered
  11.10.3 NantKwest Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 NantKwest Main Business Overview
  11.10.5 NantKwest Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Natural Killer Cell Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of NK Cell Therapies
Table 3. Major Players of NK Cell Directed Antibodies
Table 4. Natural Killer Cell Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Natural Killer Cell Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Natural Killer Cell Therapy Market Size Market Share by Type (2019-2024)
Table 7. Natural Killer Cell Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Natural Killer Cell Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Natural Killer Cell Therapy Market Size Market Share by Application (2019-2024)
Table 10. Global Natural Killer Cell Therapy Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Natural Killer Cell Therapy Revenue Market Share by Player (2019-2024)
Table 12. Natural Killer Cell Therapy Key Players Head office and Products Offered
Table 13. Natural Killer Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Natural Killer Cell Therapy Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Natural Killer Cell Therapy Market Size Market Share by Regions (2019-2024)
Table 18. Global Natural Killer Cell Therapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Natural Killer Cell Therapy Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Natural Killer Cell Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Natural Killer Cell Therapy Market Size Market Share by Country (2019-2024)
Table 22. Americas Natural Killer Cell Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Natural Killer Cell Therapy Market Size Market Share by Type (2019-2024)
Table 24. Americas Natural Killer Cell Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Natural Killer Cell Therapy Market Size Market Share by Application (2019-2024)
Table 26. APAC Natural Killer Cell Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Natural Killer Cell Therapy Market Size Market Share by Region (2019-2024)
Table 28. APAC Natural Killer Cell Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Natural Killer Cell Therapy Market Size Market Share by Type (2019-2024)
Table 30. APAC Natural Killer Cell Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Natural Killer Cell Therapy Market Size Market Share by Application (2019-2024)
Table 32. Europe Natural Killer Cell Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Natural Killer Cell Therapy Market Size Market Share by Country (2019-2024)
Table 34. Europe Natural Killer Cell Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Natural Killer Cell Therapy Market Size Market Share by Type (2019-2024)
Table 36. Europe Natural Killer Cell Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Natural Killer Cell Therapy Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Natural Killer Cell Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Natural Killer Cell Therapy Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Natural Killer Cell Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Natural Killer Cell Therapy Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Natural Killer Cell Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Natural Killer Cell Therapy Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Natural Killer Cell Therapy
Table 45. Key Market Challenges & Risks of Natural Killer Cell Therapy
Table 46. Key Industry Trends of Natural Killer Cell Therapy
Table 47. Global Natural Killer Cell Therapy Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Natural Killer Cell Therapy Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Natural Killer Cell Therapy Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Natural Killer Cell Therapy Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Nektar Therapeutics Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 52. Nektar Therapeutics Natural Killer Cell Therapy Product Offered
Table 53. Nektar Therapeutics Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Nektar Therapeutics Main Business
Table 55. Nektar Therapeutics Latest Developments
Table 56. Innate Pharma SA Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 57. Innate Pharma SA Natural Killer Cell Therapy Product Offered
Table 58. Innate Pharma SA Main Business
Table 59. Innate Pharma SA Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Innate Pharma SA Latest Developments
Table 61. Affimed Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 62. Affimed Natural Killer Cell Therapy Product Offered
Table 63. Affimed Main Business
Table 64. Affimed Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Affimed Latest Developments
Table 66. Chipscreen Biosciences Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 67. Chipscreen Biosciences Natural Killer Cell Therapy Product Offered
Table 68. Chipscreen Biosciences Main Business
Table 69. Chipscreen Biosciences Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Chipscreen Biosciences Latest Developments
Table 71. Glycostem Therapeutics Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 72. Glycostem Therapeutics Natural Killer Cell Therapy Product Offered
Table 73. Glycostem Therapeutics Main Business
Table 74. Glycostem Therapeutics Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Glycostem Therapeutics Latest Developments
Table 76. Fate Therapeutics Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 77. Fate Therapeutics Natural Killer Cell Therapy Product Offered
Table 78. Fate Therapeutics Main Business
Table 79. Fate Therapeutics Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Fate Therapeutics Latest Developments
Table 81. Dragonfly Therapeutics Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 82. Dragonfly Therapeutics Natural Killer Cell Therapy Product Offered
Table 83. Dragonfly Therapeutics Main Business
Table 84. Dragonfly Therapeutics Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Dragonfly Therapeutics Latest Developments
Table 86. Kiadis Pharma Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 87. Kiadis Pharma Natural Killer Cell Therapy Product Offered
Table 88. Kiadis Pharma Main Business
Table 89. Kiadis Pharma Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Kiadis Pharma Latest Developments
Table 91. Nkarta Therapeutics Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 92. Nkarta Therapeutics Natural Killer Cell Therapy Product Offered
Table 93. Nkarta Therapeutics Main Business
Table 94. Nkarta Therapeutics Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Nkarta Therapeutics Latest Developments
Table 96. NantKwest Details, Company Type, Natural Killer Cell Therapy Area Served and Its Competitors
Table 97. NantKwest Natural Killer Cell Therapy Product Offered
Table 98. NantKwest Main Business
Table 99. NantKwest Natural Killer Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. NantKwest Latest Developments

LIST OF FIGURES

Figure 1. Natural Killer Cell Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Natural Killer Cell Therapy Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Natural Killer Cell Therapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Natural Killer Cell Therapy Sales Market Share by Country/Region (2023)
Figure 8. Natural Killer Cell Therapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Natural Killer Cell Therapy Market Size Market Share by Type in 2023
Figure 10. Natural Killer Cell Therapy in Cancer
Figure 11. Global Natural Killer Cell Therapy Market: Cancer (2019-2024) & ($ Millions)
Figure 12. Natural Killer Cell Therapy in Gastrointestinal Diseases
Figure 13. Global Natural Killer Cell Therapy Market: Gastrointestinal Diseases (2019-2024) & ($ Millions)
Figure 14. Natural Killer Cell Therapy in Others
Figure 15. Global Natural Killer Cell Therapy Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Natural Killer Cell Therapy Market Size Market Share by Application in 2023
Figure 17. Global Natural Killer Cell Therapy Revenue Market Share by Player in 2023
Figure 18. Global Natural Killer Cell Therapy Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Natural Killer Cell Therapy Market Size 2019-2024 ($ Millions)
Figure 20. APAC Natural Killer Cell Therapy Market Size 2019-2024 ($ Millions)
Figure 21. Europe Natural Killer Cell Therapy Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Natural Killer Cell Therapy Market Size 2019-2024 ($ Millions)
Figure 23. Americas Natural Killer Cell Therapy Value Market Share by Country in 2023
Figure 24. United States Natural Killer Cell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Natural Killer Cell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Natural Killer Cell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Natural Killer Cell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Natural Killer Cell Therapy Market Size Market Share by Region in 2023
Figure 29. APAC Natural Killer Cell Therapy Market Size Market Share by Type in 2023
Figure 30. APAC Natural Killer Cell Therapy Market Size Market Share by Application in 2023
Figure 31. China Natural Killer Cell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Natural Killer Cell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Natural Killer Cell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Natural Killer Cell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Natural Killer Cell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Natural Killer Cell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Natural Killer Cell Therapy Market Size Market Share by Country in 2023
Figure 38. Europe Natural Killer Cell Therapy Market Size Market Share by Type (2019-2024)
Figure 39. Europe Natural Killer Cell Therapy Market Size Market Share by Application (2019-2024)
Figure 40. Germany Natural Killer Cell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Natural Killer Cell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Natural Killer Cell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Natural Killer Cell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Natural Killer Cell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Natural Killer Cell Therapy Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Natural Killer Cell Therapy Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Natural Killer Cell Therapy Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Natural Killer Cell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Natural Killer Cell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Natural Killer Cell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Natural Killer Cell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Natural Killer Cell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Natural Killer Cell Therapy Market Size 2025-2030 ($ Millions)
Figure 54. APAC Natural Killer Cell Therapy Market Size 2025-2030 ($ Millions)
Figure 55. Europe Natural Killer Cell Therapy Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Natural Killer Cell Therapy Market Size 2025-2030 ($ Millions)
Figure 57. United States Natural Killer Cell Therapy Market Size 2025-2030 ($ Millions)
Figure 58. Canada Natural Killer Cell Therapy Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Natural Killer Cell Therapy Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Natural Killer Cell Therapy Market Size 2025-2030 ($ Millions)
Figure 61. China Natural Killer Cell Therapy Market Size 2025-2030 ($ Millions)
Figure 62. Japan Natural Killer Cell Therapy Market Size 2025-2030 ($ Millions)
Figure 63. Korea Natural Killer Cell Therapy Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Natural Killer Cell Therapy Market Size 2025-2030 ($ Millions)
Figure 65. India Natural Killer Cell Therapy Market Size 2025-2030 ($ Millions)
Figure 66. Australia Natural Killer Cell Therapy Market Size 2025-2030 ($ Millions)
Figure 67. Germany Natural Killer Cell Therapy Market Size 2025-2030 ($ Millions)
Figure 68. France Natural Killer Cell Therapy Market Size 2025-2030 ($ Millions)
Figure 69. UK Natural Killer Cell Therapy Market Size 2025-2030 ($ Millions)
Figure 70. Italy Natural Killer Cell Therapy Market Size 2025-2030 ($ Millions)
Figure 71. Russia Natural Killer Cell Therapy Market Size 2025-2030 ($ Millions)
Figure 72. Spain Natural Killer Cell Therapy Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Natural Killer Cell Therapy Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Natural Killer Cell Therapy Market Size 2025-2030 ($ Millions)
Figure 75. Israel Natural Killer Cell Therapy Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Natural Killer Cell Therapy Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Natural Killer Cell Therapy Market Size 2025-2030 ($ Millions)
Figure 78. Global Natural Killer Cell Therapy Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Natural Killer Cell Therapy Market Size Market Share Forecast by Application (2025-2030)


More Publications